Courts Reject 2 Vioxx Verdicts | Arthritis Information

Share
 

NEW YORK TIMES
Courts Reject Two Major Vioxx Verdicts
By ALEX BERENSON
Published: May 30, 2008

Two major court victories for Merck on Thursday pushed the litigation over the painkiller Vioxx closer to conclusion and highlighted the increasing difficulty that plaintiffs’ lawyers were having in winning lawsuits against big drug companies.

For rest of article see:
 
http://www.nytimes.com/2008/05/30/business/30drug.html?ref=policy
 
Melody Peterson says drug companies pay off the FDA so they would not be objective judges.  Not a good idea.
 
Jan

This has me concerned -- from the article:

 
".... plaintiffs’ lawyers are nervously awaiting a Supreme Court ruling in a case that will be heard this fall and could bar most lawsuits against companies for injuries said to be caused by prescription medicines approved by the Food and Drug Administration.

According to the government’s and drug industry’s argument in the Supreme Court case, the F.D.A., not individual juries, should be responsible for evaluating the risks and benefits of a drug."

so this basically means if fda aprove the drug and aperson gets
seriously ill then tough luck.. then should it  be a case of the fda being
accountable and taken to court..

Boney
I for one would love for them to bring back VIOXX. It suited my body/pain/system very, very well... no side effects. I cant take ibuprofen, aspirin, and celebrex gives me heart palpitations (like VIOXX was supposed to do), so that leaves me with stronger opiod drugs which actually make me feel worse in respect of cognitive function.... bad enough having hands that dont want to type, hold a cup of tea, do the ironing, use a sweeping brush, hold the toothbrush without feeling woozy all the time.
 
Sorry, whine over!Boney,
 
I don't know if one can sue the FDA, the federal government -- probably a law against that!
 
Sarah,
 
Have you thought about the next line of RA meds - DMARDs - like plaquenil, mtx, then there's the top of the list-- the biologics, and antiobiotic protocol, which I don't know much about, but supposedly helps mild to moderate RA. 
 
I hope the Consumers Union lobbies against the FDA being judges.  A trial jury should hear these cases.
 
Jan
This Associated Press article from May 13 addresses this subject. 
 
 

Bush administration rules limit lawsuits

By PETE YOST – May 13, 2008

WASHINGTON (AP) — Faced with an unfriendly Congress, the Bush administration has found another, quieter way to make it more difficult for consumers to sue businesses over faulty products. It's rewriting the bureaucratic rulebook.

Lawsuit limits have been included in 51 rules proposed or adopted since 2005 by agency bureaucrats governing just about everything Americans use: drugs, cars, railroads, medical devices and food.

Decried by consumer advocates and embraced by industry, the agencies' use of the government's rule-making authority represents the administration's final act in a long-standing drive to shield companies from lawsuits.

President Bush has campaigned for lawsuit reform since his days as Texas governor. As president, he has made little headway on the issue in Congress. He's been thwarted by Democrats every time he's tried to tackle the issue head-on.

Turns out there was another way, one little-noticed step at a time.

If the rulemaking at the various agencies had been a centralized effort in the White House or the Justice Department, "it would have failed because immediately everybody would have mobilized resistance," said Michael Greve of the American Enterprise Institute, a conservative Washington think tank.

Limits on lawsuits have been ordered or proposed for drug labeling and packaging — one issue that will get a big airing, on Wednesday, because of a case involving actor Dennis Quaid's newborn twins — and for rules ranging from mattress flammability standards to school bus passenger seating to dietary sweeteners and roof-crush requirements in car rollovers.

Of the 51 regulations, 41 came from the Food and Drug Administration and the National Highway Traffic Safety Administration, or NHTSA.

Ten of 15 federal traffic safety regulations from last year have been finalized by NHTSA and are now in force or soon will be, a development that has gotten minimal public attention.

Underlying this bureaucratic version of lawsuit reform is the concept of federal preemption — a legal idea that is hard to build widespread public interest in.

Rooted in the Supremacy Clause of the Constitution, federal preemption refers to circumstances in which federal law and regulation trump state law, in this instance state laws that govern when one person may be held liable for another's injury.

Frequently filed in state courts, where juries often are more receptive to plaintiffs' claims against corporations, product liability lawsuits are often moved at the request of business defendants to more restrictive federal courts.

Regardless of where the suits end up, the issue is increasingly whether companies can use broad preemption language in regulatory preambles to get cases thrown out.

The preambles are the agencies' interpretation of whether the federal regulatory law permits preemption of lawsuits. An expansive interpretation of preemption leaves little room for consumers to sue, and that is what the national trial lawyers group, the American Association for Justice, says is taking place.

For rest of article see:

http://ap.google.com/article/ALeqM5gWny_K8nFBtTE0S_4OLUaKQlgChAD90KVHEO1

Joie - great thread, the links terrific.  Thanks ~~ CathyYour welcome Cathy.    I think some of us, myself included, don't follow some of these Supreme Court cases, cuz the legal-speak can be hard to follow, but this is about a citizen's right to legal recourse should they be injured as a result of a company's negligence.  Since most of us here take prescription drugs, this directly infringes on our right to a jury trial in a state court if we or a loved one become victim to a company's faulty product. 
 
From the AP article:
 
"Later this year, the Supreme Court will wade into the issue of federal preemption as it relates to lawsuits and prescription drug labeling. The defendant drugmaker contends it should not be in the lawsuit because the FDA had approved the warning label on the drug.

The company is trying to overturn a .8 million award given a woman whose arm had to be amputated after anti-nausea medication was inadvertently injected into an artery."

 

Copyright ArthritisInsight.com